School of Forensic and Applied Sciences, University of Central Lancashire, Preston, England, PR1 2HE, UK.
Faculty of Medicine and Health Sciences, University of Guyana, Turkeyen, Georgetown, Guyana.
Mol Cell Biochem. 2018 Dec;449(1-2):9-25. doi: 10.1007/s11010-018-3338-4. Epub 2018 Feb 23.
There is much evidence that diabetes mellitus (DM)-induced hyperglycemia (HG) is responsible for kidney failure or nephropathy leading to cardiovascular complications. Cellular and molecular mechanism(s) whereby DM can damage the kidney is still not fully understood. This study investigated the effect of streptozotocin (STZ)-induced diabetes (T1DM) on the structure and associated molecular alterations of the isolated rat left kidney following 2 and 4 months of the disorder compared to the respective age-matched controls. The results revealed hypertrophy and general disorganized architecture of the kidney characterized by expansion in glomerular borders, tubular atrophy and increased vacuolization of renal tubular epithelial cells in the diabetic groups compared to controls. Electron microscopic analysis revealed ultrastructural alterations in the left kidney highlighted by an increase in glomerular basement membrane width. In addition, increased caspase-3 immunoreactivity was observed in the kidney of T1DM animals compared to age-matched controls. These structural changes were associated with elevated extracellular matrix (ECM) deposition and consequently, altered gene expression profile of ECM key components, together with elevated levels of key mediators (MMP9, integrin 5α, TIMP4, CTGF, vimentin) and reduced expressions of Cx43 and MMP2 of the ECM. Marked hypertrophy of the kidney was highlighted by increased atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) gene expression. These changes also correlated with increased TGFβ1 activity, gene expression in the left kidney and elevated active TGFβ1 in the plasma of T1DM rats compared to control. The results clearly demonstrated that TIDM could elicit severe structural changes and alteration in biochemical markers (remodelling) in the kidney leading to diabetic nephropathy (DN).
有大量证据表明,糖尿病(DM)引起的高血糖(HG)是导致肾衰竭或肾病导致心血管并发症的原因。DM 如何损害肾脏的细胞和分子机制尚不完全清楚。本研究调查了链脲佐菌素(STZ)诱导的糖尿病(T1DM)对 2 个月和 4 个月后分离的大鼠左肾结构及其相关分子改变的影响,与相应的年龄匹配对照组相比。结果显示,与对照组相比,糖尿病组的肾脏表现为肥大和整体组织结构紊乱,肾小球边界扩张,肾小管萎缩,肾小管上皮细胞空泡化增加。电子显微镜分析显示,左肾的超微结构改变,肾小球基底膜宽度增加。此外,与年龄匹配的对照组相比,T1DM 动物的肾脏中 caspase-3 免疫反应性增加。这些结构变化与细胞外基质(ECM)沉积增加有关,因此 ECM 关键成分的基因表达谱发生改变,同时关键介质(MMP9、整合素 5α、TIMP4、CTGF、波形蛋白)水平升高,ECM 的 Cx43 和 MMP2 表达降低。肾脏明显肥大,心房利钠肽(ANP)和脑利钠肽(BNP)基因表达增加。这些变化也与左肾 TGFβ1 活性、基因表达的增加以及 T1DM 大鼠血浆中活性 TGFβ1 的升高有关。结果清楚地表明,TIDM 可引起肾脏严重的结构变化和生化标志物(重塑)的改变,导致糖尿病肾病(DN)。